FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004235757> ?p ?o ?g. }

• W2004235757 endingPage "643" @default.
• W2004235757 startingPage "637" @default.
• W2004235757 abstract "BackgroundWe compared morbidity, mortality, and oncological results of bronchial and/or vascular sleeve lobectomy (SL) with those of pneumonectomy (PN) after induction therapy for lung cancer.MethodsBetween 1998 and 2011, 82 patients receiving induction therapy (chemo or chemo-radiotherapy) for non–small-cell-lung-cancer underwent sleeve lobectomy (n = 39) or pneumonectomy (n= 43). Only patients undergoing preoperative chemotherapy (39 in the SL group and 39 in the PN group) were included in the study. SL was bronchial in 21, vascular in 12, and broncho-vascular in six cases, respectively. Clinical stage before induction therapy was IIb in seven patients (1 in PN group; 6 in SL group), IIIa in 66 (36 in PN group; 30 in SL group), and IIIb in five patients (2 in PN group; 3 in SL group), respectively. N3 patients were not included in this series.ResultsThe rate of downstaged patients (pathological complete response and stage I–II) was 79.5% in the SL group and 53.8% in the PN group (p = 0.01).Postpneumonectomy mortality rate was 2.6 %. There was no postoperative mortality after SL. Complications occurred in 12 patients (30.8%) after PN and in 11 patients (28.2%) after SL (p = 0.6). Three-year and 5-year survival rates were 68 ± 3% and 64 ± 8% in the SL group; and 59.5 ± 5% and 34.5 ± 8% in the PN group (p = 0.02). The difference in terms of recurrence rate (locoregional and distant) between the two groups was not significant (p = 0.2).ConclusionsSL represents a valid therapeutic option even after induction chemotherapy, providing better long-term survival than PN, with no increase of postoperative complications or recurrence rate. Pathological downstaging is a favorable prognostic factor. We compared morbidity, mortality, and oncological results of bronchial and/or vascular sleeve lobectomy (SL) with those of pneumonectomy (PN) after induction therapy for lung cancer. Between 1998 and 2011, 82 patients receiving induction therapy (chemo or chemo-radiotherapy) for non–small-cell-lung-cancer underwent sleeve lobectomy (n = 39) or pneumonectomy (n= 43). Only patients undergoing preoperative chemotherapy (39 in the SL group and 39 in the PN group) were included in the study. SL was bronchial in 21, vascular in 12, and broncho-vascular in six cases, respectively. Clinical stage before induction therapy was IIb in seven patients (1 in PN group; 6 in SL group), IIIa in 66 (36 in PN group; 30 in SL group), and IIIb in five patients (2 in PN group; 3 in SL group), respectively. N3 patients were not included in this series. The rate of downstaged patients (pathological complete response and stage I–II) was 79.5% in the SL group and 53.8% in the PN group (p = 0.01).Postpneumonectomy mortality rate was 2.6 %. There was no postoperative mortality after SL. Complications occurred in 12 patients (30.8%) after PN and in 11 patients (28.2%) after SL (p = 0.6). Three-year and 5-year survival rates were 68 ± 3% and 64 ± 8% in the SL group; and 59.5 ± 5% and 34.5 ± 8% in the PN group (p = 0.02). The difference in terms of recurrence rate (locoregional and distant) between the two groups was not significant (p = 0.2). SL represents a valid therapeutic option even after induction chemotherapy, providing better long-term survival than PN, with no increase of postoperative complications or recurrence rate. Pathological downstaging is a favorable prognostic factor." @default.
• W2004235757 created "2016-06-24" @default.
• W2004235757 creator A5008396992 @default.
• W2004235757 creator A5025153023 @default.
• W2004235757 creator A5038761572 @default.
• W2004235757 creator A5058545847 @default.
• W2004235757 creator A5076122854 @default.
• W2004235757 creator A5089032781 @default.
• W2004235757 creator A5089270717 @default.
• W2004235757 date "2013-05-01" @default.
• W2004235757 modified "2023-10-16" @default.
• W2004235757 title "Sleeve Lobectomy Compared with Pneumonectomy after Induction Therapy for Non–Small-Cell Lung Cancer" @default.
• W2004235757 cites W1826494426 @default.
• W2004235757 cites W1964091904 @default.
• W2004235757 cites W1967648552 @default.
• W2004235757 cites W1993285288 @default.
• W2004235757 cites W2000446386 @default.
• W2004235757 cites W2003085867 @default.
• W2004235757 cites W2020187541 @default.
• W2004235757 cites W2023392415 @default.
• W2004235757 cites W2041860748 @default.
• W2004235757 cites W2064644796 @default.
• W2004235757 cites W2070156173 @default.
• W2004235757 cites W2089966530 @default.
• W2004235757 cites W2096226636 @default.
• W2004235757 cites W2108271903 @default.
• W2004235757 cites W2110996227 @default.
• W2004235757 cites W2116986733 @default.
• W2004235757 cites W2122446287 @default.
• W2004235757 cites W2124567064 @default.
• W2004235757 cites W2125138302 @default.
• W2004235757 cites W2138559340 @default.
• W2004235757 cites W2141167137 @default.
• W2004235757 cites W2146614007 @default.
• W2004235757 cites W2153710105 @default.
• W2004235757 cites W2155280448 @default.
• W2004235757 cites W2160708645 @default.
• W2004235757 cites W2164747160 @default.
• W2004235757 cites W2205360056 @default.
• W2004235757 cites W2411239115 @default.
• W2004235757 doi "https://doi.org/10.1097/jto.0b013e318286d145" @default.
• W2004235757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23584296" @default.
• W2004235757 hasPublicationYear "2013" @default.
• W2004235757 type Work @default.
• W2004235757 sameAs 2004235757 @default.
• W2004235757 citedByCount "56" @default.
• W2004235757 countsByYear W20042357572013 @default.
• W2004235757 countsByYear W20042357572014 @default.
• W2004235757 countsByYear W20042357572015 @default.
• W2004235757 countsByYear W20042357572016 @default.
• W2004235757 countsByYear W20042357572017 @default.
• W2004235757 countsByYear W20042357572018 @default.
• W2004235757 countsByYear W20042357572019 @default.
• W2004235757 countsByYear W20042357572020 @default.
• W2004235757 countsByYear W20042357572021 @default.
• W2004235757 countsByYear W20042357572022 @default.
• W2004235757 countsByYear W20042357572023 @default.
• W2004235757 crossrefType "journal-article" @default.
• W2004235757 hasAuthorship W2004235757A5008396992 @default.
• W2004235757 hasAuthorship W2004235757A5025153023 @default.
• W2004235757 hasAuthorship W2004235757A5038761572 @default.
• W2004235757 hasAuthorship W2004235757A5058545847 @default.
• W2004235757 hasAuthorship W2004235757A5076122854 @default.
• W2004235757 hasAuthorship W2004235757A5089032781 @default.
• W2004235757 hasAuthorship W2004235757A5089270717 @default.
• W2004235757 hasBestOaLocation W20042357571 @default.
• W2004235757 hasConcept C126322002 @default.
• W2004235757 hasConcept C141071460 @default.
• W2004235757 hasConcept C146357865 @default.
• W2004235757 hasConcept C151730666 @default.
• W2004235757 hasConcept C2776256026 @default.
• W2004235757 hasConcept C2776283816 @default.
• W2004235757 hasConcept C2776611710 @default.
• W2004235757 hasConcept C2776694085 @default.
• W2004235757 hasConcept C2777589429 @default.
• W2004235757 hasConcept C509974204 @default.
• W2004235757 hasConcept C71924100 @default.
• W2004235757 hasConcept C86803240 @default.
• W2004235757 hasConcept C90924648 @default.
• W2004235757 hasConceptScore W2004235757C126322002 @default.
• W2004235757 hasConceptScore W2004235757C141071460 @default.
• W2004235757 hasConceptScore W2004235757C146357865 @default.
• W2004235757 hasConceptScore W2004235757C151730666 @default.
• W2004235757 hasConceptScore W2004235757C2776256026 @default.
• W2004235757 hasConceptScore W2004235757C2776283816 @default.
• W2004235757 hasConceptScore W2004235757C2776611710 @default.
• W2004235757 hasConceptScore W2004235757C2776694085 @default.
• W2004235757 hasConceptScore W2004235757C2777589429 @default.
• W2004235757 hasConceptScore W2004235757C509974204 @default.
• W2004235757 hasConceptScore W2004235757C71924100 @default.
• W2004235757 hasConceptScore W2004235757C86803240 @default.
• W2004235757 hasConceptScore W2004235757C90924648 @default.
• W2004235757 hasIssue "5" @default.
• W2004235757 hasLocation W20042357571 @default.
• W2004235757 hasLocation W20042357572 @default.
• W2004235757 hasOpenAccess W2004235757 @default.
• W2004235757 hasPrimaryLocation W20042357571 @default.
• W2004235757 hasRelatedWork W103340260 @default.

• next